Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma
Clinical trial NCT07555470 · RECRUITING
Trial details
- NCT number
- NCT07555470
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2029-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.